In vitro photoinactivation of bovine mastitis related pathogens

Photodiagnosis and Photodynamic Therapy

Volumn 13, Issue , 2016, Pages 276-281

  Sellera, Fábio Parra ^a   Sabino, Caetano Padial ^b   Ribeiro, Martha Simões ^b   Gargano, Ronaldo Gomes ^a   Benites, Nilson Roberti ^a   Melville, Priscilla Anne ^a   Pogliani, Fabio Celidonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centre for Lasers and Applications (CLA)   (Brazil)

Author keywords

Antimicrobial; Dairy cows; Photodynamic inactivation; Treatment; Veterinary medicine

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALEXIN; CEFALOTIN; CEFTIOFUR; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ENROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; METHYLENE BLUE; OXACILLIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN; PHOTOSENSITIZING AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BOVINE MASTITIS; CONTROLLED STUDY; CORYNEBACTERIUM; CORYNEBACTERIUM BOVIS; IN VITRO STUDY; IRRADIATION; LIGHT EMITTING DIODE; NONHUMAN; PHOTODYNAMIC INACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTOTHECA ZOPFII; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; TREATMENT OUTCOME; ANIMAL; BACTERIAL PHENOMENA AND FUNCTIONS; BOVINE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; INSTRUMENT STERILIZATION; MASTITIS, BOVINE; MICROBIOLOGY; MILK; PATHOLOGY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROCEDURES; PROTOTHECA; RADIATION RESPONSE;

ANIMALS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CATTLE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; MASTITIS, BOVINE; MILK; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOTHECA; STERILIZATION;

EID: 84960811036     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2015.08.007     Document Type: Article

References (62)

1. Bradley A. Bovine mastitis: an evolving disease. Vet. J. 2002, 164:116-128.
2. Grummer R.R. Impact of changes in organic nutrient metabolism on feeding the transition dairy cow. J. Anim. Sci. 1995, 73:2820-2833.
3. Mulligan F.J., Doherty M.L. Production diseases of the transition cow. Vet. J. 2008, 176:3-9.
4. Della Libera A.M., de Souza F.N., Batista C.F., Santos B.P., de Azevedo L.F., Sanchez E.M., Diniz S.A., Silva M.X., Haddad J.P., Blagitz M.G. Effects of bovine leukemia virus infection on milk neutrophil function and the milk lymphocyte profile. Vet. Res. 2015, 46:2-8.
5. Kimura K., Goff J.P., Kehrli M.E., Harp J.A., Nonnecke B.J. Effects of mastectomy on composition of peripheral blood mononuclear cell populations in periparturient dairy cows. J. Dairy Sci. 2002, 85:1437-1444.
6. LeBlanc S.J., Lissemore K.D., Kelton D.F., Duffield T.F., Leslie K.E. Major advances in disease prevention in dairy cattle. J. Dairy. Sci. 2006, 89:1267-1279.
7. Roberson J.R. Treatment of clinical mastitis. Vet. Clin. North Am. Food Anim. Pract. 2012, 28:271-288.
8. Deb R., Kumar A., Chakraborty S., Verma A.K., Tiwari R., Dhama K., Singh U., Kumar S. Trends in diagnosis and control of bovine mastitis: a review. Pak. J. Biol. Sci. 2013, 16:1653-1661.
9. Bauman D.E., Currie W.B. Partitioning of nutrients during pregnancy and lactation: a review of mechanisms involving homeostasis and homeorhesis. J. Dairy Sci. 1980, 63:1514-1529.
10. Kneebone J., Tsang P.C., Townson D.H. Short communication: rapid antibiotic screening tests detect antibiotic residues in powdered milk products. J. Dairy Sci. 2010, 93:3961-3964.
11. Whittem T., Whittem J.H., Constable P.D. Modelling the concentration-time relationship in milk from cattle administered an intramammary drug. J. Vet. Pharmacol. Ther. 2012, 35:460-471.
12. Conzuelo F., Campuzano S., Gamella M., Pinacho D.G., Reviejo A.J., Marco M.P., Pingarrón J.M. Integrated disposable electrochemical immunosensors for the simultaneous determination of sulfonamide and tetracycline antibiotics residues in milk. Biosens. Bioelectron. 2013, 15:100-105.
13. Moon J.S., Lee A.R., Kang H.M., Lee E.S., Kim M.N., Paik Y.H., Park Y.H., Joo Y.S., Koo H.C. Phenotypic and genetic antibiogram of methicillin-resistant staphylococci isolated from bovine mastitis in Korea. J. Dairy Sci. 2007, 90:1176-1185.
14. Saini V., McClure J.T., Léger D., Keefe G.P., Scholl D.T., Morck D.W., Barkema H.W. Antimicrobial resistance profiles of common mastitis pathogens on Canadian dairy farms. J. Dairy Sci. 2012, 5:4319-4332.
15. Jamali H., Radmehr B., Ismail S. Short communication: prevalence and antibiotic resistance of Staphylococcus aureus isolated from bovine clinical mastitis. J. Dairy Sci. 2014, 97:2226-2230.
16. Hamblin M.R., Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem. Photobiol. Sci. 2004, 3:436-450.
17. Jori G., Magaraggia M., Fabris C., Soncin M., Camerin M., Tallandini L., Coppellotti O., Guidolin L. Photodynamic inactivation of microbial pathogens: disinfection of water and prevention of water-borne diseases. J. Environ. Pathol. Toxicol. Oncol. 2011, 30:261-271.
18. Wardlaw J.L., Sullivan T.J., Lux C.N., Austin F.W. Photodynamic therapy against common bacteria causing wound and skin infections. Vet. J. 2012, 192:374-377.
19. Garcez A.S., Núñez S.C., Azambuja N.J., regnani E.R., Rodriguez H.M., Hamblin M.R., Suzuki H., Ribeiro M.S. Effects of photodynamic therapy on Gram-positive and Gram-negative bacterial biofilms by bioluminescence imaging and scanning electron microscopic analysis. Photomed. Laser Surg. 2013, 31:519-525.
20. Wainwright M., Amaral L. The phenothiazinium chromophore and the evolution of antimalarial drugs. Trop. Med. Int. Health 2005, 10:501-511.
21. Dai T., Huang Y.Y., Hamblin M.R. Photodynamic therapy for localized infections-state of the art. Photodiagn. Photodyn. Ther. 2009, 6:170-188.
22. Souto L.I., Minagawa C.Y., Telles E.O., Garbuglio M.A., Amaku M., Dias R.A., Sakata S.T., Benites N.R. Relationship between occurrence of mastitis pathogens in dairy cattle herds and raw-milk indicators of hygienic-sanitary quality. J. Dairy Res. 2008, 75:121-127.
23. Martins R.P., da Silva J.A.G., Nakazato L., Dutra V., Almeida Filho E.S. Prevalence and infectious etiology of bovine mastitis in the microregion of Cuiabá, MT, Brazil. Ciênc. Anim. Bras. 2010, 11:181-187.
24. Costa G.M., Paiva L.V., Figueiredo H.C., Figueira A.R., Pereira U.P., Silva N. Population diversity of Staphylococcus aureus isolated from bovine mastitis in Brazilian dairy herds. Res. Vet. Sci. 2012, 93:733-735.
25. Sobukawa H., Watanabe M., Kano R., Ito T., Onozaki M., Hasegawa A., Kamata H. In vitro algaecide effect of disinfectants on Prototheca zopfii genotypes 1 and 2. J. Vet. Med. Sci. 2011, 73:1527-1529.
26. Gonçalves J.L., Lee S.H., Arruda E.P., Galles D.P., Caetano V.C., Fernandes de Oliveira C.A., Fernandes A.M., Veiga Dos Santos M. Biofilm-producing ability and efficiency of sanitizing agents against Prototheca zopfii isolates from bovine subclinical mastitis. J. Dairy Sci. 2015, in press.
27. Murray P.R., Baron E.J., Jorgensen J.H., Landry M.L., Pfaller M.A. Manual of Clinical Microbiology 2007, ASM Press., Washington, DC, U.S.A. 9th ed.
28. Pore R.S. Prototheca Krüger. The Yeasts: A Taxonomic Study 1998, 883-887. Elsevier. C.P. Kurtzman, J.W. Fell (Eds.).
29. Bauer A.W., Kirby W.M., Sherris J.C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966, 45:493.
30. CLSI (Clinical, Laboratory Standards Institute) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animal. Approved Standard 2008, Clinical and Laboratory Standards Institute, Wayne, PA, U.S.A, ISBN: 1- 56,238-660-3CLSI document M31-A3. third ed.
31. Prates R.A., Silva E.G., Yamada A.E., Suzuki L.C., Paula C.R., Ribeiro M.S. Light parameters influence cell viability in antifungal photodynamic therapy in a fluence and rate fluence-dependent manner. Laser Phys. 2009, 19:1038-1044.
32. Pfaller M.A., Burmeister L., Bartlett M.S., Rinaldi M.G. Multicenter evaluation of four methods of yeast inoculum preparation. J. Clin. Microbiol. 1988, 26:1437-1441.
33. Jett B.D., Hatter K.L., Huycke M.M., Gilmore M.S. Simplified agar plate method for quantifying viable bacteria. Biotechniques 1997, 23:648-650.
34. Tseng S.P., Teng L.J., Chen C.T., Lo T.H., Hung W.C., Chen H.J., Hsueh P.R., Tsai J.C. Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa. Lasers Surg. Med. 2009, 41:391-397.
35. Tegos G.P., Hamblin M. Phenotiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob. Agents Chemother. 2006, 50:196-203.
36. George S., Hamblin M.R., Kishen A. Uptake pathways of anionic and cationic photosensitizers into bacteria. Photochem. Photobiol. Sci. 2009, 8:788-795.
37. Sommerhäuser J., Kloppert B., Wolter W., Zschöck M., Sobiraj A., Failing K. The epidemiology of Staphylococcus aureus infections from subclinical mastitis in dairy cows during a control programme. Vet. Microbiol. 2003, 96:91-102.
38. Pol M., Ruegg P.L. Relationship between antimicrobial drug usage and antimicrobial susceptibility of Gram-positive mastitis pathogens. J. Dairy Sci. 2007, 90:262-273.
39. Dai T., Fuchs B.B., Coleman J.J., Prates R.A., Astrakas C., St Denis T.G., Ribeiro M.S., Mylonakis E., Hamblin M.R., Tegos G.P. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front. Microbiol. 2012, 3:120.
40. Leonel Gonçalves J., Hwa In Lee S., de Paula Arruda E., Pedroso Galles D., Camargo Caetano V., Fernandes de Oliveira C.A., Fernandes A.M., Veiga Dos Santos M. Biofilm-producing ability and efficiency of sanitizing agents against Prototheca zopfii isolates from bovine subclinical mastitis. J. Dairy Sci. 2015, 98:3613-3621.
41. Calzavara-Pinton P.G., Venturini M., Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J. Photochem. Photobiol. B. Biol. 2005, 78:1-6.
42. Demidova T.N., Hamblin M.R. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl. Environ. Microbiol. 2005, 71:6918-6925.
43. Chibebe J., Fuchs B.B., Sabino C.P., Junqueira J.C., Jorge A.O., Ribeiro M.S., Gilmore M.S., Rice L.B., Tegos G.P., Hamblin M.R., Mylonakis E. Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model. PLoS One 2013, 8:e55926.
44. Chibebe J., Sabino C.P., Tan X., Junqueira J.C., Wang Y., Fuchs B.B., Jorge A.O., Tegos G.P., Hamblin M.R., Mylonakis E. Selective photoinactivation of Candida albicans in the non-vertebrate host infection model Galleria mellonella. BMC Microbiol. 2013, 13:217.
45. Soukos N., Wilson M., Burns T., Speight P. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro. Lasers Surg. Med. 1996, 18:253-259.
46. Haddad R., Kaplan O., Brazovski E., Rabau M., Schneebaum S., Shnaper A., Skornick Y., Kashtan H. Effect of photodynamic therapy on normal fibroblasts and colon anastomotic healing in mice. J. Gastrointest. Surg. 1999, 3:602-606.
47. Tanaka M., Kinoshita M., Yoshihara Y., Shinomiya N., Seki S., Nemoto K., Hirayama T., Dai T., Huang L., Hamblin M.R., Morimoto Y. Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem. Photobiol. 2011, 88:227-232.
48. Noodt B.B., Rodal G.H., Wainwright M., Peng Q., Horobin R., Nesland J.M., Berg K. Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int. J. Cancer 1998, 75:941-948.
49. Zeina B., Greenman J., Corry D., Purcell W.M. Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br. J. Dermatol. 2002, 146:568-573.
50. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 2006, 6:535-545.
51. Sabino C.P., Garcez A.S., Núñez S.C., Ribeiro M.S., Hamblin M.R. Real-time evaluation of two light delivery systems for photodynamic disinfection of Candida albicans biofilm in curved root canals. Lasers Med. Sci 2014, in press.
52. Ganz R.A., Viveiros J., Ahmad A., Ahmadi A., Khalil A., Tolkoff M.J., Nishioka N.S., Hamblin M.R. Helicobacter pylori in patients can be killed by visible light. Lasers Surg. Med. 2005, 36:260-265.
53. Kato H. Our experience with photodynamic diagnosis and photodynamic therapy for lung cancer. J. Natl. Compr. Cancer Netw. 2012, 1:3-8.
54. Bader M.J., Stepp H., Beyer W., Pongratz T., Sroka R., Kriegmair M., Zaak D., Welschof M., Tilki D., Stief C.G., Waidelich R. Photodynamic therapy of bladder cancer-a phase I study using hexaminolevulinate (HAL). Urol. Oncol. 2013, 31:1178-1183.
55. Yano T., Hatogai K., Morimoto H., Yoda Y., Kaneko K. Photodynamic therapy for esophageal cancer. Ann. Transl. Med. 2014, 2:29.
56. Miller B.M., Sauer A., Moraru C.I. Inactivation of Escherichia coli in milk and concentrated milk using pulsed-light treatment. J. Dairy Sci. 2012, 95:5597-5603.
57. Simões A., Platero M.D., Campos L., Aranha A.C., Eduardo C.D.E.P., Nicolau J. Laser as a therapy for dry mouth symptoms in a patient with Sjögren's syndrome: a case report. Spec. Care Dentist. 2009, 9:134-137.
58. Lončar B., Stipetić M.M., Baričević M., Risović D. The effect of low-level laser therapy on salivary glands in patients with xerostomia. Photomed. Laser Surg. 2011, 29:171-175.
59. Fabris C., Soncin M., Corsi F., Cattin I., Jori G. Treatment of spontaneous piodermitis in dogs by PDT using porphyrin-type photosensitisers. Photodiagnosis Photodyn. Ther. 2011, 11:138.
60. Buchholz J., Walt H. Veterinary photodynamic therapy: a review. Photodiagn. Photodyn. Ther. 2013, 10:342-347.
61. Sellera F.P., Sabino C.P., Ribeiro M.S., Fernandes L.T., Pogliani F.C., Teixeira C.R., Dutra G.H.P., Nascimento C.L. Photodynamic therapy for pododermatitis in penguins. Zoo Biol. 2014, 33:353-356.
62. Nascimento C.L., Ribeiro M.S., Sellera F.P., Dutra G.H., Simões A., Teixeira C.R. Comparative study between photodynamic and antibiotic therapies for treatment of footpad dermatitis (bumblefoot) in Magellanic penguins (Spheniscus magellanicus). Photodiagn. Photodyn. Ther. 2015, 12:36-44.